Health Tip: Understanding Alopecia Areata
-- Alopecia areata is a form of hair loss that ' s triggered by your immune system mistakenly viewing hair follicles as threats to your health.
This can trigger patchy hair loss on the head, complete hair loss on the head or the loss of body hair, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2019 Category: General Medicine Source Type: news
Health Tip: Understanding Alopecia Areata
Title: Health Tip: Understanding Alopecia AreataCategory: Health NewsCreated: 2/14/2019 12:00:00 AMLast Editorial Review: 2/14/2019 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - February 14, 2019 Category: Dermatology Source Type: news
ASK THE GP: Dr Martin Scurr answers your health questions
The Daily Mail's resident doctor answers your personal concerns in his weekly Good Health column. Today, he advises on a mild form of alopecia areata. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2019 Category: Consumer Health News Source Type: news
Pfizer initiates phase 2b/3 clinical trial for PF-06651600, an oral JAK3 inhibitor, for the treatment of patients with moderate to severe alopecia areata
Pfizer Inc. (NYSE: PFE) announced the initiation of a Phase 2b/3 clinical trial for its oral JAK3 inhibitor, PF-06651600, for the treatment of patients with moderate to severe alopecia areata, a chronic autoimmune skin disease that causes hair loss on the scalp, face, or body, and currently has no approved therapies. (Source: World Pharma News)
Source: World Pharma News - January 5, 2019 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
Alopecia Areata: A Review of Disease Pathogenesis Alopecia Areata: A Review of Disease Pathogenesis
This article offers new insights into the pathophysiological mechanisms involved in the etiology of alopecia areata, an incurable autoimmune disorder.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Oral JAK3 Inhibitors Show Potential to Boost Hair Growth
(MedPage Today) -- Investigational agents efficacious in moderate-to-severe alopecia areata (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 17, 2018 Category: Dermatology Source Type: news
JAK Inhibitors Promising for Alopecia Areata JAK Inhibitors Promising for Alopecia Areata
Two investigational new drugs are emerging for patients with moderate to severe hair loss, for whom there are currently no reliable treatments.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 17, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news
JAK Agents Impress in Alopecia Areata
(MedPage Today) -- Significant hair growth with two different drugs (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 17, 2018 Category: Dermatology Source Type: news
Alopecia Areata Trial Results, Skin Oncology Top EADV Agenda Alopecia Areata Trial Results, Skin Oncology Top EADV Agenda
Early results from a trial of JAK inhibitors for hair loss will be unveiled at the upcoming dermatology meeting. Specialists will also delve into the adverse skin effects of immunotherapy.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 29, 2018 Category: Consumer Health News Tags: Dermatology News Source Type: news
Janus Kinase Inhibitors: Emerging Applications in Dermatology Janus Kinase Inhibitors: Emerging Applications in Dermatology
Learn about the use of Janus kinase inhibitors, which have become promising treatment options for dermatologic conditions such as psoriasis, atopic dermatitis, alopecia areata, vilitigo, and more.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 22, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
Fecal Transplant Promising Primary Therapy for C diff Fecal Transplant Promising Primary Therapy for C diff
Fecal microbiota transplantation can be used for the first-line treatment of C difficile, and it might also have an effect on neurologic and autoimmune diseases, such as autism and alopecia areata.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 19, 2018 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Alopecia Areata
Title: Alopecia AreataCategory: Diseases and ConditionsCreated: 4/30/1999 12:00:00 AMLast Editorial Review: 3/28/2018 12:00:00 AM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - March 28, 2018 Category: Dermatology Source Type: news
Alopecia Areata: Who Gets Screened for Thyroid Disease? Alopecia Areata: Who Gets Screened for Thyroid Disease?
Many children with alopecia areata get screened for thyroid disease. But do they all need to be?CHOP Expert Commentary (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 2, 2018 Category: Consumer Health News Tags: Pediatrics Expert Interview Source Type: news
Thyroid Screening Advised for Some Kids with Alopecia Areata
(MedPage Today) -- Those with atopy, Down syndrome, and familial history may be at increased risk (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - September 27, 2017 Category: Dermatology Source Type: news
Bullying and quality of life in pediatric alopecia areata - Christensen T, Yang JS, Castelo-Soccio L.
We report survey result... (Source: SafetyLit)
Source: SafetyLit - September 9, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
